Danijela Štrbac

558 total citations
12 papers, 50 citations indexed

About

Danijela Štrbac is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Danijela Štrbac has authored 12 papers receiving a total of 50 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Danijela Štrbac's work include Occupational and environmental lung diseases (9 papers), Protease and Inhibitor Mechanisms (3 papers) and Occupational exposure and asthma (3 papers). Danijela Štrbac is often cited by papers focused on Occupational and environmental lung diseases (9 papers), Protease and Inhibitor Mechanisms (3 papers) and Occupational exposure and asthma (3 papers). Danijela Štrbac collaborates with scholars based in Slovenia. Danijela Štrbac's co-authors include Vita Dolžan, Viljem Kovač, Katja Goričar, Metoda Dodič-Fikfak, Maja Česen, Sneẑana Šušnjar, Matjaž Zwitter, Aleš Rozman, Zora Nešković‐Konstantinović and Lorna Zadravec Zaletel and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Thoracic Oncology and Biomolecules.

In The Last Decade

Danijela Štrbac

10 papers receiving 50 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danijela Štrbac Slovenia 5 39 13 9 6 6 12 50
Alicia López-Abad Spain 5 25 0.6× 9 0.7× 10 1.1× 8 1.3× 8 1.3× 23 53
Claire Smith United Kingdom 5 28 0.7× 20 1.5× 3 0.3× 10 1.7× 3 0.5× 5 63
Padraig Hawkins Ireland 4 42 1.1× 16 1.2× 3 0.3× 7 1.2× 10 1.7× 11 63
Miklos Perenyei United Kingdom 3 13 0.3× 5 0.4× 3 0.3× 5 0.8× 7 1.2× 9 49
Benjamin Wadowski United States 5 51 1.3× 3 0.2× 3 0.3× 11 1.8× 4 0.7× 10 69
Beatriz Rojas Spain 3 7 0.2× 11 0.8× 3 0.3× 18 3.0× 5 0.8× 7 30
Thomas R Muley Germany 3 18 0.5× 12 0.9× 2 0.2× 11 1.8× 5 0.8× 4 38
Jennifer Margrave United States 2 47 1.2× 18 1.4× 2 0.2× 12 2.0× 3 55
Vesna Pavasovic United Kingdom 4 14 0.4× 7 0.5× 16 1.8× 12 2.0× 5 0.8× 8 49
Catherine Sperlich Canada 4 19 0.5× 3 0.2× 2 0.2× 10 1.7× 3 0.5× 8 33

Countries citing papers authored by Danijela Štrbac

Since Specialization
Citations

This map shows the geographic impact of Danijela Štrbac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danijela Štrbac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danijela Štrbac more than expected).

Fields of papers citing papers by Danijela Štrbac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danijela Štrbac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danijela Štrbac. The network helps show where Danijela Štrbac may publish in the future.

Co-authorship network of co-authors of Danijela Štrbac

This figure shows the co-authorship network connecting the top 25 collaborators of Danijela Štrbac. A scholar is included among the top collaborators of Danijela Štrbac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danijela Štrbac. Danijela Štrbac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Štrbac, Danijela, et al.. (2024). Ocular adnexal lymphoma – a retrospective study and review of the literature. Radiology and Oncology. 58(3). 416–424. 1 indexed citations
2.
Štrbac, Danijela, et al.. (2023). Serum Calretinin and Genetic Variability as a Prognostic and Predictive Factor in Malignant Mesothelioma. International Journal of Molecular Sciences. 25(1). 190–190. 3 indexed citations
3.
Štrbac, Danijela, et al.. (2023). The association of genetic factors with serum calretinin levels in asbestos-related diseases. Radiology and Oncology. 57(4). 473–486. 1 indexed citations
5.
Štrbac, Danijela & Vita Dolžan. (2022). Novel and Future Treatment Options in Mesothelioma: A Systematic Review. International Journal of Molecular Sciences. 23(4). 1975–1975. 10 indexed citations
6.
Štrbac, Danijela, et al.. (2021). Serum Calretinin as a Biomarker in Malignant Mesothelioma. Journal of Clinical Medicine. 10(21). 4875–4875. 5 indexed citations
7.
Štrbac, Danijela & Vita Dolžan. (2021). Matrix Metalloproteinases as Biomarkers and Treatment Targets in Mesothelioma: A Systematic Review. Biomolecules. 11(9). 1272–1272. 2 indexed citations
8.
Štrbac, Danijela, Katja Goričar, Vita Dolžan, & Viljem Kovač. (2019). Evaluation of Matrix Metalloproteinase 9 Serum Concentration as a Biomarker in Malignant Mesothelioma. Disease Markers. 2019. 1–8. 6 indexed citations
9.
Štrbac, Danijela, Katja Goričar, Vita Dolžan, & Viljem Kovač. (2018). Matrix metalloproteinases polymorphisms as baseline risk predictors in malignant pleural mesothelioma. Radiology and Oncology. 52(2). 160–166. 9 indexed citations
10.
Kovač, Viljem, Matjaž Zwitter, Danijela Štrbac, et al.. (2017). P3.03-030 Cisplatin with Pemetrexed or Gemcitabine in Prolonged Infusion for Inoperable Mesothelioma: A Phase II Randomized Trial. Journal of Thoracic Oncology. 12(1). S1362–S1363. 2 indexed citations
11.
Štrbac, Danijela, Katja Goričar, Vita Dolžan, & Viljem Kovač. (2017). Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma. Disease Markers. 2017. 1–8. 11 indexed citations
12.
Nešković‐Konstantinović, Zora, et al.. (2004). Factors influencing the amenorrhea caused by anthracycline chemotherapy regimens in premenopausal breast cancer patients. European Journal of Cancer Supplements. 2(3). 141–142.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026